TY - JOUR
T1 - Proteomic analysis of hippocampal proteins of F344 rats exposed to 1-bromopropane
AU - Huang, Zhenlie
AU - Ichihara, Sahoko
AU - Oikawa, Shinji
AU - Chang, Jie
AU - Zhang, Lingyi
AU - Takahashi, Masahide
AU - Subramanian, Kaviarasan
AU - Mohideen, Sahabudeen Sheik
AU - Wang, Yun
AU - Ichihara, Gaku
N1 - Funding Information:
This work was funded in part by the Japanese Society for the Promotion of Science (grant-in-aid # 22390120 and LS056 ).
PY - 2011/11/15
Y1 - 2011/11/15
N2 - 1-Bromopropane (1-BP) is a compound used as an alternative to ozone-depleting solvents and is neurotoxic both in experimental animals and human. However, the molecular mechanisms of the neurotoxic effects of 1-BP are not well known. To identify the molecular mechanisms of 1-BP-induced neurotoxicity, we analyzed quantitatively changes in protein expression in the hippocampus of rats exposed to 1-BP. Male F344 rats were exposed to 1-BP at 0, 400, or 1000. ppm for 8. h/day for 1 or 4. weeks by inhalation. Two-dimensional difference in gel electrophoresis (2D-DIGE) combined with matrix-assisted laser-desorption ionization time-of-flight (MALDI-TOF) mass spectrometry (MS) were conducted to detect and identify protein modification. Changes in selected proteins were further confirmed by western blot. 2D-DIGE identified 26 proteins with consistently altered model (increase or decrease after both 1- and 4-week 1-BP exposures) and significant changes in their levels (p<0.05; fold change ≥ ±. 1.2) at least at one exposure level or more compared with the corresponding controls. Of these proteins, 19 were identified by MALDI-TOF-TOF/MS. Linear regression analysis of 1-BP exposure level identified 8 differentially expressed proteins altered in a dose-dependent manner both in 1- and 4-week exposure experiments. The identified proteins could be categorized into diverse functional classes such as nucleocytoplasmic transport, immunity and defense, energy metabolism, ubiquitination-proteasome pathway, neurotransmitter and purine metabolism. Overall, the results suggest that 1-BP-induced hippocampal damage involves oxidative stress, loss of ATP production, neurotransmitter dysfunction and inhibition of ubiquitination-proteasome system.
AB - 1-Bromopropane (1-BP) is a compound used as an alternative to ozone-depleting solvents and is neurotoxic both in experimental animals and human. However, the molecular mechanisms of the neurotoxic effects of 1-BP are not well known. To identify the molecular mechanisms of 1-BP-induced neurotoxicity, we analyzed quantitatively changes in protein expression in the hippocampus of rats exposed to 1-BP. Male F344 rats were exposed to 1-BP at 0, 400, or 1000. ppm for 8. h/day for 1 or 4. weeks by inhalation. Two-dimensional difference in gel electrophoresis (2D-DIGE) combined with matrix-assisted laser-desorption ionization time-of-flight (MALDI-TOF) mass spectrometry (MS) were conducted to detect and identify protein modification. Changes in selected proteins were further confirmed by western blot. 2D-DIGE identified 26 proteins with consistently altered model (increase or decrease after both 1- and 4-week 1-BP exposures) and significant changes in their levels (p<0.05; fold change ≥ ±. 1.2) at least at one exposure level or more compared with the corresponding controls. Of these proteins, 19 were identified by MALDI-TOF-TOF/MS. Linear regression analysis of 1-BP exposure level identified 8 differentially expressed proteins altered in a dose-dependent manner both in 1- and 4-week exposure experiments. The identified proteins could be categorized into diverse functional classes such as nucleocytoplasmic transport, immunity and defense, energy metabolism, ubiquitination-proteasome pathway, neurotransmitter and purine metabolism. Overall, the results suggest that 1-BP-induced hippocampal damage involves oxidative stress, loss of ATP production, neurotransmitter dysfunction and inhibition of ubiquitination-proteasome system.
UR - http://www.scopus.com/inward/record.url?scp=81255134304&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=81255134304&partnerID=8YFLogxK
U2 - 10.1016/j.taap.2011.08.023
DO - 10.1016/j.taap.2011.08.023
M3 - Article
C2 - 21925529
AN - SCOPUS:81255134304
SN - 0041-008X
VL - 257
SP - 93
EP - 101
JO - Toxicology and applied pharmacology
JF - Toxicology and applied pharmacology
IS - 1
ER -